These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 693563)

  • 21. Chronic administration of D-amphetamine increases [3H]spiroperidol binding in cat brain.
    Trulson ME; Crisp T
    Eur J Pharmacol; 1985 Nov; 117(2):267-70. PubMed ID: 4076345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of SCH23390 and spiperone on the expression of conditioned place preference induced by d-amphetamine or cocaine in the rat.
    Liao RM; Chang YH; Wang SH
    Chin J Physiol; 1998 Jun; 41(2):85-92. PubMed ID: 9801838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of behavioral supersensitivity to d-amphetamine after pimozide withdrawal. A trial with schizophrenic patients.
    van Kammen DP; Docherty JP; Marder SR; Schulz SC; Bunney WE
    Arch Gen Psychiatry; 1980 Mar; 37(3):287-90. PubMed ID: 6102456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of agonists and antagonists of D1 and D2 dopamine receptors on self-stimulation of the medial prefrontal cortex in the rat.
    Ferrer JM; Sanguinetti AM; Vives F; Mora F
    Pharmacol Biochem Behav; 1983 Aug; 19(2):211-7. PubMed ID: 6138775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of early relapse after pimozide discontinuation by response to d-amphetamine during pimozide treatment.
    van Kammen DP; Docherty JP; Bunney WE
    Biol Psychiatry; 1982 Feb; 17(2):233-42. PubMed ID: 7074181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral and neurochemical alterations after lithium-pilocarpine administration in young and adult rats: a comparative study.
    De Bruin VM; Marinho MM; De Sousa FC; Viana GS
    Pharmacol Biochem Behav; 2000 Mar; 65(3):547-51. PubMed ID: 10683497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paradoxical effects of d-amphetamine on behavioral thermoregulation: possible mediation by brain dopamine.
    Yehuda S; Wurtman RJ
    J Pharmacol Exp Ther; 1974 Jul; 190(1):118-22. PubMed ID: 4367895
    [No Abstract]   [Full Text] [Related]  

  • 28. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers.
    Brauer LH; de Wit H
    Biol Psychiatry; 1996 Jan; 39(1):26-32. PubMed ID: 8719123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine receptor subtypes and formalin test analgesia.
    Morgan MJ; Franklin KB
    Pharmacol Biochem Behav; 1991 Oct; 40(2):317-22. PubMed ID: 1687167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pilocarpine reversal of D-amphetamine induced increase in mouse exploratory locomotor activity.
    Proctor CD; Potts JL; Ashley LG; Denefield BA
    Arch Int Pharmacodyn Ther; 1967 May; 167(1):61-8. PubMed ID: 6035105
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of dopamine supersensitivity on lateral hypothalamic self-stimulation in rats.
    Ettenberg A; Milner PM
    Pharmacol Biochem Behav; 1977 Dec; 7(6):507-14. PubMed ID: 563603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opposed stages of continuous amphetamine administration: parallel alterations in motor stereotypies and in vivo spiroperidol accumulation.
    Ellison G; Morris W
    Eur J Pharmacol; 1981 Sep; 74(2-3):207-14. PubMed ID: 7198992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time sampling observation procedure for studying drug effects: interaction between d-amphetamine and selective dopamine receptor antagonists in the rat.
    Petry N; Furmidge L; Tong ZY; Martin C; Clark D
    Pharmacol Biochem Behav; 1993 Jan; 44(1):167-80. PubMed ID: 8430120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous rate-independent and rate-dependent assessment of intracranial self-stimulation: evidence for the direct involvement of dopamine in brain reinforcement mechanisms.
    Zarevics P; Setler PE
    Brain Res; 1979 Jun; 169(3):499-512. PubMed ID: 312681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A behavioral analysis of aggressive behaviors induced and modulated by delta9-tetrahydrocannabinol, pilocarpine, d-amphetamine and l-dopa [proceedings].
    Miczek KA
    Act Nerv Super (Praha); 1977 Sep; 19(3):224-5. PubMed ID: 562581
    [No Abstract]   [Full Text] [Related]  

  • 36. Involvement of central dopamine in the hyperthermia in rats produced by d-amphetamine.
    Ulus IH; Kiran BK; Ozkurt S
    Pharmacology; 1975; 13(4):309-16. PubMed ID: 1187755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of cholinergic and dopaminergic influences on yawning behavior.
    Holmgren B; Urbá-Holmgren R
    Acta Neurobiol Exp (Wars); 1980; 40(3):633-42. PubMed ID: 6969021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of dopamine D1 and D2 receptors in mediating the d-amphetamine discriminative cue.
    Furmidge LJ; Exner M; Clark D
    Eur J Pharmacol; 1991 Sep; 202(2):191-9. PubMed ID: 1687032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amphetamine discrimination: effects of dopamine receptor agonists.
    Nielsen EB; Randrup K; Andersen PH
    Eur J Pharmacol; 1989 Jan; 160(2):253-62. PubMed ID: 2569406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for an inhibitory dopaminergic and stimulatory noradrenergic hypothalamic influence on PMS-induced ovulation in the immature rat. II. A pharmacological analysis.
    Löfström A; Agnati LF; Fuxe K; Hökfelt T
    Neuroendocrinology; 1977; 24(5-6):289-316. PubMed ID: 347324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.